Benvida Film Coated Tablet 150 Mg

Description

The Core Component

Benvida’s efficacy hinges on its core ingredient, Lakozamid.

Active Ingredient
– Lakozamid 150 mg

Additional Components

In addition to Lakozamid, the tablet incorporates several auxiliary substances, enhancing its pharmaceutical properties.

• Kroskarmeloz sodyum 18.75 mg
• Sodyum stearil fumarat 5.625 mg
• Sodyum bikarbonat 0.0144 mg

Pharmaceutical Form

The tablets come with a film coating, boasting a distinctive salmon color, oblong shape, and biconvex profile.

Therapeutic Indications

Benvida, enriched with Lakozamid, is a therapeutic marvel, primarily prescribed for the treatment of partial-onset seizures. It demonstrates efficacy in both adolescent (16-18 years) and adult patients with epilepsy. This versatile medication can be employed as both monotherapy and adjunctive therapy.

Dosage

The recommended dosage of Benvida Film Coated Tablet 150 Mg hinges on the intended use, be it monotherapy or adjunctive therapy.

Monotherapy

• Starting Dose: Initiate with 50 mg twice a day.
• Therapeutic Threshold: After a week, escalate to a therapeutic dose of 100 mg twice a day.
• Gradual Adjustments: Based on treatment response and tolerability, increase the maintenance dose by increments of 50 mg twice a day (100 mg/day) weekly.
• Maximum Daily Dose: The regimen may culminate in a maximum daily dose of 300 mg twice a day (600 mg/day).

Adjunctive Therapy

• Initial Dosage: Begin with 50 mg twice a day.
• Therapeutic Threshold: After a week, progress to a therapeutic dose of 100 mg twice a day.
• Gradual Adjustments: Based on treatment response and tolerability, increase the maintenance dose by increments of 50 mg twice a day (100 mg/day) every week.
• Maximum Daily Dose: The maximum daily dose for adjunctive therapy reaches 200 mg twice a day.

Please be mindful that these are general dosage guidelines. Precise dosage requirements may deviate based on individual health profiles. For personalized medical advice, always consult with a healthcare provider.

Side Effects

Adopters of this medication should be vigilant regarding potential side effects, some of which encompass:

• Suicidal Thoughts or Actions
• Chest Pain
• Abnormal Sensations (Burning, Numbness, Tingling)
• Inability to Control Eye Movements

Precautions

General Precautions

• Kidney Health: Benvida may pose a risk to kidney health, particularly in cases of dehydration, concurrent use of diuretic medication (water pills), or pre-existing kidney disease.
• Calcium Levels: A potential side effect is low blood calcium levels.
• Oral Health: Patients may experience mouth or jaw pain.
• Allergic Reactions: Signs of an allergic reaction include hives, wheezing, breathing difficulties, and facial swelling.

Specific Precautions

• Missed Dose: In the event of a missed dose, patients should promptly take the omitted dose, followed by the next scheduled Lakozamid dose.
• Discontinuation Alert: Abruptly halting the medication can elevate the risk of seizures.
• Maintaining Alertness: Activities requiring attentiveness, such as driving, should be approached with caution until the impact of the medication is understood.
• Rising Gradually: To mitigate dizziness or fainting, individuals transitioning from a seated or reclined position should do so gradually.

These precautions offer a broad perspective, but individual circumstances may warrant unique considerations. Consult with a healthcare provider for tailored guidance.

Benvida Film Coated Tablet 150 Mg Benefits

Benvida Film Coated Tablet 150 Mg, powered by the active ingredient Lakozamid, emerges as a potent tool in epilepsy management, boasting a range of benefits:

• Seizure Control: Lakozamid curtails abnormal nerve cell activity in the brain, effectively controlling seizures.
• Therapeutic Flexibility: It can be utilized both as monotherapy and adjunctive therapy, offering diverse treatment avenues.
• Twice-Daily Convenience: Administered twice a day, Benvida’s dosing regimen is conducive for patient adherence.

It’s important to acknowledge that while these advantages are promising, individual responses may vary. Thus, personalized medical advice from a healthcare provider is paramount.

Determining the Duration

The timeline for using Benvida Film Coated Tablet 150 Mg is contingent on the patient’s response and the specific condition being addressed. To ensure optimal outcomes, adhere to your healthcare provider’s guidance regarding treatment duration. Abruptly discontinuing the medication is discouraged, as it can heighten the risk of seizures.

Conclusion

In conclusion, Benvida Film Coated Tablet 150 Mg, fortified with Lakozamid, offers a valuable solution for epilepsy management. With its potential to control seizures, versatile administration, and considered precautions, it stands as a significant asset in the quest for improved quality of life for those affected by epilepsy. Always partner with your healthcare provider to chart the most suitable course of action tailored to your unique health profile.